GlassScriptPhysician profile
Morris J Gist
NPI 1902879851
$4,313.94
in general payments reported to CMS, 2019-2025
29 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,082 · 2020: $346 · 2021: $194 · 2022: $366 · 2023: $85.05 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.61 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,101.72 | 2019-2020 | |
| Astellas Pharma US INC | $423.92 | 2019-2023 | |
| Pfizer INC. | $295.65 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $226.69 | 2019-2022 | |
| Teleflex LLC | $194.27 | 2021-2025 | Barrigel |
| Procept Biorobotics Corporation | $136.43 | 2025 | |
| Janssen Biotech, INC. | $122.07 | 2019-2025 | Erleada |
| Ferring Pharmaceuticals INC. | $84.73 | 2019 | |
| Coloplast Corp | $77.10 | 2020-2021 | |
| 180 Medical, INC. | $71.92 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $68.30 | 2019 | |
| Therapeuticsmd, INC. | $56.15 | 2019 | |
| Amgen INC. | $53.34 | 2019 | |
| Boston Scientific Corporation | $52.76 | 2019 | |
| Dentsply Ih INC. | $41.39 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $39.77 | 2025 | Proxis Ureteral Access Sheath |
| Urogen Pharma, INC. | $36.59 | 2022-2025 | |
| Antares Pharma, INC. | $29.98 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $23.86 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $23.64 | 2022 | |
| Clovis Oncology, INC. | $22.73 | 2020 | |
| Baudax Bio INC. | $22.72 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.31 | 2020 | |
| Blue Earth Diagnostics | $19.14 | 2019 | |
| Agiliti Surgical, INC. | $18.53 | 2019 | |
| Verity Pharmaceuticals INC. | $17.50 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.90 | 2022 | |
| Ambu INC. | $10.42 | 2021 | |
| Travere Therapeutics, INC. | $4.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morris Gist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.